CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study

Raffaele Altara, Marco Manca, Marleen H. Hessel, Yumei Gu, Laura C. van Vark, K. Martijn Akkerhuis, Jan A. Staessen, H. Struyker Boudier, George W. Booz, Matthijs Blankesteijn

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)302-314
JournalJournal of Cardiovascular Translational Research
Volume9
Issue number4
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Chemokines
  • Inflammation
  • Immune response
  • CXCR3

Cite this

Altara, R., Manca, M., Hessel, M. H., Gu, Y., van Vark, L. C., Akkerhuis, K. M., Staessen, J. A., Struyker Boudier, H., Booz, G. W., & Blankesteijn, M. (2016). CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study. Journal of Cardiovascular Translational Research, 9(4), 302-314. https://doi.org/10.1007/s12265-016-9703-3